“COVID-19 is uncharted territory,” writes Beth Snyder Bulk in FiercePharma, “an unprecedented global public health crisis amid a global economic collapse. Consumers who already felt ‘screwed’ by increasing insurance deductibles and drug co-pays before COVID-19 are now under even further economic stress, Jane Sarasohn-Kahn said. From the consumers’ point of view? ‘This is a public health issue and we’re broke,'” I soberly noted.
Jane quoted in FiercePharma’s analysis on how Remdesivir will be priced – Gilead in no-win situation…
By Jane Sarasohn-Kahn on 8 May 2020 in




I'm gratified to be named on
I’m celebrating America’s 250th birthday both patriotically and professionally, honored that the NLM included my 2010 paper, “How Smartphones Are Changing Healthcare for Consumers and Patients” as one of 250 items curated for the digital archive of 250 Years of American Medicine.
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global health care enterprise.